Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation

The therapeutic effects of simvastatin for renal cell carcinoma (RCC) are controversial. In this study, the effects of simvastatin on the carcinogenic properties of 3-methylcholanthrene (3MC; an aryl-hydrocarbon receptor [AhR] agonist) in human renal epithelial cells (hRECs) were investigated. We ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chih-Cheng, Huang, Kuo-How, Hsu, Sung-Po, Lee, Yuan-Chii G., Sue, Yuh-Mou, Juan, Shu-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418087/
https://www.ncbi.nlm.nih.gov/pubmed/30872677
http://dx.doi.org/10.1038/s41598-019-40757-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418087/
https://www.ncbi.nlm.nih.gov/pubmed/30872677
http://dx.doi.org/10.1038/s41598-019-40757-6

Ejemplares similares